Kantoff PW - Search Results

1

EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent.

Xu K, Wu ZJ, Groner AC, He HH, Cai C, Lis RT, Wu X, Stack EC, Loda M, Liu T, Xu H, Cato L, Thornton JE, Gregory RI, Morrissey C, Vessella RL, Montironi R, Magi-Galluzzi C, Kantoff PW, Balk SP, Liu XS, Brown M. Xu K, et al. Among authors: kantoff pw. Science. 2012 Dec 14;338(6113):1465-9. doi: 10.1126/science.1227604. Science. 2012. PMID: 23239736 Free PMC article.

2

The CAG repeat within the androgen receptor gene and its relationship to prostate cancer.

Giovannucci E, Stampfer MJ, Krithivas K, Brown M, Dahl D, Brufsky A, Talcott J, Hennekens CH, Kantoff PW. Giovannucci E, et al. Among authors: kantoff pw. Proc Natl Acad Sci U S A. 1997 Apr 1;94(7):3320-3. doi: 10.1073/pnas.94.7.3320. Proc Natl Acad Sci U S A. 1997. PMID: 9096391 Free PMC article.

3

A polymorphism of the 5 alpha-reductase gene and its association with prostate cancer: a case-control analysis.

Kantoff PW, Febbo PG, Giovannucci E, Krithivas K, Dahl DM, Chang G, Hennekens CH, Brown M, Stampfer MJ. Kantoff PW, et al. Cancer Epidemiol Biomarkers Prev. 1997 Mar;6(3):189-92. Cancer Epidemiol Biomarkers Prev. 1997. PMID: 9138662

4

Debrisoquine hydroxylase (CYP2D6) and prostate cancer.

Febbo PG, Kantoff PW, Giovannucci E, Brown M, Chang G, Hennekens CH, Stampfer M. Febbo PG, et al. Among authors: kantoff pw. Cancer Epidemiol Biomarkers Prev. 1998 Dec;7(12):1075-8. Cancer Epidemiol Biomarkers Prev. 1998. PMID: 9865424

5

The androgen receptor CAG repeat polymorphism and its relationship to prostate cancer.

Kantoff P, Giovannucci E, Brown M. Kantoff P, et al. Biochim Biophys Acta. 1998 Nov 26;1378(3):C1-5. doi: 10.1016/s0304-419x(98)00023-7. Biochim Biophys Acta. 1998. PMID: 9875243 Review. No abstract available.

6

Evidence that the CAG repeat in the androgen receptor gene is associated with the age-related decline in serum androgen levels in men.

Krithivas K, Yurgalevitch SM, Mohr BA, Wilcox CJ, Batter SJ, Brown M, Longcope C, McKinlay JB, Kantoff PW. Krithivas K, et al. Among authors: kantoff pw. J Endocrinol. 1999 Jul;162(1):137-42. doi: 10.1677/joe.0.1620137. J Endocrinol. 1999. PMID: 10396030

7

Antiandrogens in prostate cancer.

Reid P, Kantoff P, Oh W. Reid P, et al. Invest New Drugs. 1999;17(3):271-84. doi: 10.1023/a:1006344807086. Invest New Drugs. 1999. PMID: 10665479 Review.

8

Her-2-neu expression and progression toward androgen independence in human prostate cancer.

Signoretti S, Montironi R, Manola J, Altimari A, Tam C, Bubley G, Balk S, Thomas G, Kaplan I, Hlatky L, Hahnfeldt P, Kantoff P, Loda M. Signoretti S, et al. J Natl Cancer Inst. 2000 Dec 6;92(23):1918-25. doi: 10.1093/jnci/92.23.1918. J Natl Cancer Inst. 2000. PMID: 11106683

9

Progressive sclerosis of isolated foot metastasis of prostate cancer.

Oh WK, Loda M, Kantoff PW, Janicek M. Oh WK, et al. Among authors: kantoff pw. J Urol. 2002 Mar;167(3):1392. J Urol. 2002. PMID: 11832744 No abstract available.

10

The androgen receptor CAG repeat polymorphism and risk of breast cancer in the Nurses' Health Study.

Haiman CA, Brown M, Hankinson SE, Spiegelman D, Colditz GA, Willett WC, Kantoff PW, Hunter DJ. Haiman CA, et al. Among authors: kantoff pw. Cancer Res. 2002 Feb 15;62(4):1045-9. Cancer Res. 2002. PMID: 11861380

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

482 results

Search Page

Filters